Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (559) Paxil CR (paroxetine hydrochloride), SmithKline Beecham,
...Newly Approved Drug Therapies (559) Paxil CR (paroxetine hydrochloride), SmithKline Beecham, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Paxil CR (paroxetine hydrochloride) Company: SmithKline Beecham Approval Status: Approved March 1999 Treatment Area: Psychiatry General Information Paxil ...
View Page

2. Clinical Trial Results by Drug Names
...Trial Results by Drug Names Clinical Trial Result Information Title of Study: A placebo- and paroxetine-controlled study of efficacy and safety. Fast Facts: Protocol number: BN16568 Sponsor: Hoffmann-La Roche ...
...1/2006 Clinical study summary: This double-blind randomized study compared the effect of RO0675930, paroxetine and placebo on the symptoms of major depressive disorder. Patients were randomized to receive either ...
View Page

3. Clinical Trial Results by Drug Names
...Trial Results by Drug Names Clinical Trial Result Information Title of Study: A Placebo- and Paroxetine-Controlled Study of Efficacy and Safety. Fast Facts: Protocol number: BN16430 Sponsor: Roche Laboratories Inc ...
...1/2005 Clinical study summary: This double-blind, randomized study compared the effect of RO0675930, paroxetine and placebo on the symptoms of major depressive disorder. Patients were randomized to receive either ...
View Page

4.  Newly Approved Drug Therapies (104) Paxil (paroxetine hydrochloride), SmithKline Beecham,
...Newly Approved Drug Therapies (104) Paxil (paroxetine hydrochloride), SmithKline Beecham, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Paxil (paroxetine hydrochloride) Company: SmithKline Beecham Approval Status: Approved May 1996 Treatment Area: panic disorder, obsessive-compulsive ...
View Page

5.  Newly Approved Drug Therapies (766) Paxil CR (paroxetine hydrochloride), GlaxoSmithKline,
...Newly Approved Drug Therapies (766) Paxil CR (paroxetine hydrochloride), GlaxoSmithKline, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Paxil CR (paroxetine hydrochloride) Company: GlaxoSmithKline Approval Status: Approved February 2002 Treatment Area: Depression, panic disorder General Information ...
View Page

6. Advanced/Specific Search Results NK1 Inhibitor [NK1 Inhibitor]
...NK1 Inhibitor [NK1 Inhibitor] Date of Report: 12/1/2005 Phase: II A Placebo- and Paroxetine-Controlled Study of Efficacy and Safety. Product Name: NK1 Inhibitor [NK1 Inhibitor] Date of Report: 1/1/2006 Phase: II A placebo- and paroxetine-controlled study of efficacy and safety. Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 Jobson ...
View Page

7.  Study Posting (1887) Trial #89534, Social Anxiety Disorder (SAD), New York, NY
...Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects with Social Anxiety Disorder." /> Trial Information Social Anxiety Disorder Research Study A Randomized ...
...Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects with Social Anxiety Disorder. Social Anxiety Disorder (SAD, formerly called social phobia) is ...
View Page

8. Clinical Trial Results: Depression (Major/Severe)
...NK1 Inhibitor [NK1 Inhibitor] Date of Report: 12/1/2005 Phase: II A Placebo- and Paroxetine-Controlled Study of Efficacy and Safety. Product Name: NK1 Inhibitor [NK1 Inhibitor] Date of Report: 1/1/2006 Phase: II A placebo- and paroxetine-controlled study of efficacy and safety. Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 Jobson ...
View Page

9.  CenterWatch: Clinical Trials in Category (483) Social Anxiety Disorder (SAD)
...Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects with Social Anxiety Disorder. Texas Houston : Bayou City Research Corporation Is your child ...
View Page

10.  CenterWatch: Psychiatry/Psychology Approved Drug Therapies
...reuptake inhibitor useful for the treatment for major depressive disorder, Approved August 2002 Paxil CR (paroxetine hydrochloride) ; GlaxoSmithKline; Oral tablet for the treatment of depression and panic disorder, Approved February 2002 ...
...1999 Effexor (venlafaxin HCL) ; Wyeth; Treatment for generalized anxiety disorder, Approved March 1999 Paxil CR (paroxetine hydrochloride) ; SmithKline Beecham; Treatment for depression, Approved March 1999 Sonata ; American Home Products; Treatment fo ...
View Page

11.  CenterWatch Clinical Research Profile (4328) Trial #1833, Aurora Cuevro Clinical Trials, Miami, FL
...Randomized, Double-Blind, Placebo-Controlled, Flexible Dosage Trial to Evaluate the Efficacy and Tolerability of Paroxetine CR in Patients with Generalized Anxiety Disorder (GAD). SmithKline Beecham, Miami, FL, 2001-2002. 38 ...
...Phase IV, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Study Evaluating Efficacy and Safety of Paroxetine Controlled Release (12.5 and 25mg/day) versus Placebo in Patients with Major Depressive Disorder ...
View Page

12.  Study Posting (2348) Trial #53934, Body Dysmorphic Disorder, New York, NY
...8 weeks prior to entering the program: fluoxetine (Prozac), fluvoxamine (Luvox), venlafaxine (Effexor), clomipramine (Anafranil), paroxetine (Paxil), citalopram (Celexa) or sertraline (Zoloft). Subjects should not be on any other forms of ...
View Page

13.  CenterWatch Clinical Research Profile (961) Trial #465, CRI Worldwide, Mount Laurel, NJ
...Medical Publishing, Inc.; the posters “Mirtazapine vs. Sertraline after SSRI Non-Response” and “Mirtazapine vs. Paroxetine in Elderly Depressed Patients”; articles such as “Antidepressants for the Treatment of Generalized Anxiety Disorder ...
...R. Riesenberg; P. Ripley; L. Rone; G. Small; A. Strauss; and K. Weiss; "Mirtazapine Versus Paroxetine in Elderly Depressed Patients;" presented at the ECNP meeting in Munich, Germany September 2000. • W ...
View Page

14.  Newly Approved Drug Therapies (865) Cymbalta (duloxetine), Eli Lilly,
...Demitrack MA. Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine. J Clin Psychopharmacol . 2004 Aug; 24(4): 389-99. Wohlreich MM, Watkin JG. The Role ...
View Page

15.  CenterWatch Clinical Research Profile (2338) Trial #1132, The William W. Backus Hospital, Norwich, CT
...Antipsychotics (Eli Lilly & Co.) Principal Investigator - A Phase IIB, Seven-Week, Double-Blind, Placebo- and Paroxetine-Controlled Multicenter Study to Evaluate the Safety and Efficacy of Oral CP-122,721 in ...
View Page

16.  CenterWatch: List of Newly Approved Drug Thearapies
...1996 Nicotrol transdermal patch ; McNeil Consumer Products; Treatment for smoking cessation, Approved July 1996 Paxil (paroxetine hydrochloride) ; SmithKline Beecham; Treatment for panic disorder, Approved May 1996 Redux (dexfenfluramine hydrochloride) ; Wyeth; Treatment ...
View Page

17.  CenterWatch: List of Newly Approved Drug Thearapies
...Psychology Effexor (venlafaxin HCL) ; Wyeth; Treatment for generalized anxiety disorder, Approved March 1999 Paxil CR (paroxetine hydrochloride) ; SmithKline Beecham; Treatment for depression, Approved March 1999 Sonata ; American Home Products; Treatment fo ...
View Page

18.  CenterWatch: List of Newly Approved Drug Thearapies
...reuptake inhibitor useful for the treatment for major depressive disorder, Approved August 2002 Paxil CR (paroxetine hydrochloride) ; GlaxoSmithKline; Oral tablet for the treatment of depression and panic disorder, Approved February 2002 ...
View Page